Cargando…
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as alternatives to classical monotarget therapies and microRNAs are of particular interest in that regard. MicroRNA research has come a long way from their initial discovery to the cumulative appreciation of their...
Autores principales: | Walgrave, Hannah, Zhou, Lujia, De Strooper, Bart, Salta, Evgenia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572071/ https://www.ncbi.nlm.nih.gov/pubmed/34742333 http://dx.doi.org/10.1186/s13024-021-00496-7 |
Ejemplares similares
-
microRNA-132 regulates gene expression programs involved in microglial homeostasis
por: Walgrave, Hannah, et al.
Publicado: (2023) -
Alteration of the microRNA network during the progression of Alzheimer's disease
por: Lau, Pierre, et al.
Publicado: (2013) -
miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
por: Salta, Evgenia, et al.
Publicado: (2016) -
MicroRNA silencing: A promising therapy for Alzheimer’s disease
por: Chauhan, Neelima B.
Publicado: (2020) -
Diabetes Complications: The MicroRNA Perspective
por: Kantharidis, Phillip, et al.
Publicado: (2011)